TABLE 2

Disease severity, comorbidities, and clinical and laboratory data on admission of patients with cardiovascular events (CVEs)

AMIOther CVEp-value
Patients n21107
Demographics
 Females12 (57)55 (51)0.630
 Age years79 (72–85)83 (75–88)0.258
Severity on admission
 PSI risk class V17 (81)53 (50)0.007
 Severe sepsis15 (71)43 (40)0.009
Comorbidities
 Active neoplastic disease5 (24)14 (13)0.206
 Chronic obstructive pulmonary disease9 (43)35 (33)0.371
 Diabetes mellitus4 (19)25 (23)0.666
 Prior cerebrovascular accident10 (48)33 (31)0.137
 Liver disease5 (24)1 (0.9)<0.001
 Neurological diseases7 (33)33 (31)0.822
 Renal disease2 (9.5)10 (9.3)0.980
 Chronic renal failure7 (33)13 (12)0.015
 Immunosuppression#6 (29)14 (13)0.074
 Family history of coronary artery disease6 (29)18 (17)0.207
 Essential arterial hypertension11 (52)63 (59)0.581
 Congestive heart failure9 (43)33 (31)0.284
 Coronary artery disease8 (38)29 (27)0.310
 Prior acute myocardial infarction4 (19)19 (18)0.888
 Atrial fibrillation6 (29)27 (25)0.749
 Hyperlipidaemia7 (33)19 (18)0.105
Medications before admission
 Aspirin10 (48)41 (38)0.426
 β-blockers6 (29)26 (24)0.679
 ACE inhibitors6 (29)36 (34)0.651
 Warfarin2 (9.5)5 (4.7)0.371
 Heparin0 (0)5 (4.7)0.312
 Antiplatelets1 (4.8)15 (14)0.241
 Statins4 (19)10 (10)0.253
Clinical and laboratory data on admission
 Platelets >450 000 per μL4 (20)4 (3.8)0.006
 Lactate dehydrogenase mg·dL−1510 (389–725)391 (321–502)0.036
 Triglycerides mg·dL−1108 (93–157)94 (72–117)0.041
 Glucose mg·dL−1168 (132–225)128 (109–183)0.033
 Cholesterol mg·dL−1 mean±sd178±72148±350.034
  • Data are presented as n (%) or median (interquartile range), unless otherwise stated. AMI: acute myocardial infarction; PSI: Pneumonia Severity Index; ACE: angiotensin-converting enzyme. #: presence of at least one of active cancer, asplenia or HIV infection.